Clinical trial evidence + real world data: How do we ensure equal access to optimal CLL care

Key Points

• Equal access to care is crucial for improving outcomes in chronic lymphocytic leukemia (CLL), and disparities exist.
• Clinical trials often do not represent the general population, leading to gaps in real-world data.
• Recommendations suggest integrating real world data with clinical trial findings to enhance patient care.
• Addressing access disparities may enable more equitable treatment and better health outcomes for CLL patients.